Clinical Trial Update: Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining the combination of calcitriol and docetaxel in patients with metastatic or locally advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Calcitriol (calcitriol)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED